Wednesday, September 14, 2016

BRIEF-U.S. FDA panel votes in favor of removing boxed warning on Pfizer's quit-smoking drug Chantix

* 10 Of 19 panelists to FDA vote in favor of removing boxed

warning of serious neuropsychiatric side effects on Pfizer's

quit-smoking drug Chantix

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)